Potassium Phosphates has 6 known drug interactions based on U.S. FDA drug labeling data. Of these, 6 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Angiotensin Ii, Cyclosporine, Digoxin. Patients taking Potassium Phosphates should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 6
- Contraindicated
- 6
Contraindicated (6)
- Potassium Phosphates + Angiotensin Ii— Increases risk of severe and potentially fatal hyperkalemia. Avoid use; if unavoidable, closely monitor serum potassium.
- Potassium Phosphates + Cyclosporine— Immunosuppressant that increases serum potassium, raising risk of severe and potentially fatal hyperkalemia. Avoid use; …
- Potassium Phosphates + Digoxin— Increases risk of severe and potentially fatal hyperkalemia. Avoid use; if unavoidable, closely monitor serum potassium.
- Potassium Phosphates + Mao Inhibitors— Increases risk of severe and potentially fatal hyperkalemia. Avoid use; if unavoidable, closely monitor serum potassium.
- Potassium Phosphates + Potassium Supplements— Increases risk of severe and potentially fatal hyperkalemia. Avoid use; if unavoidable, closely monitor serum potassium.
- Potassium Phosphates + Tacrolimus— Immunosuppressant that increases serum potassium, raising risk of severe and potentially fatal hyperkalemia. Avoid use; …